BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9677277)

  • 1. A new cacospongionolide inhibitor of human secretory phospholipase A2 from the Tyrrhenian sponge Fasciospongia cavernosa and absolute configuration of cacospongionolides.
    De Rosa S; Crispino A; De Giulio A; Iodice C; Benrezzouk R; Terencio MC; Ferrándiz ML; Alcaraz MJ; Payá M
    J Nat Prod; 1998 Jul; 61(7):931-5. PubMed ID: 9677277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new cacospongionolide derivative from the sponge Fasciospongia cavernosa.
    De Rosa S; Crispino A; De Giulio A; Iodice C; Amodeo P; Tancredi T
    J Nat Prod; 1999 Sep; 62(9):1316-8. PubMed ID: 10514323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cacospongionolide B, a new sesterterpene from the sponge Fasciospongia cavernosa.
    De Rosa S; Crispino A; De Giulio A; Iodice C; Pronzato R; Zavodnik N
    J Nat Prod; 1995 Nov; 58(11):1776-80. PubMed ID: 8594155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Petrosaspongiolides M-R: new potent and selective phospholipase A2 inhibitors from the New Caledonian marine sponge Petrosaspongia nigra.
    Randazzo A; Debitus C; Minale L; García Pastor P; Alcaraz MJ; Payá M; Gomez-Paloma L
    J Nat Prod; 1998 May; 61(5):571-5. PubMed ID: 9599251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of acute and chronic inflammatory processes by cacospongionolide B, a novel inhibitor of human synovial phospholipase A2.
    García Pastor P; De Rosa S; De Giulio A; Payá M; Alcaraz MJ
    Br J Pharmacol; 1999 Jan; 126(1):301-11. PubMed ID: 10051149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total syntheses of (+)- and (-)-cacospongionolide B, cacospongionolide e, and related analogues. Preliminary study of structural features required for phospholipase a2 inhibition.
    Cheung AK; Murelli R; Snapper ML
    J Org Chem; 2004 Aug; 69(17):5712-9. PubMed ID: 15307744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformationally restricted (+)-cacospongionolide B analogues. Influence on secretory phospholipase A2 inhibition.
    Murelli RP; Cheung AK; Snapper ML
    J Org Chem; 2007 Mar; 72(5):1545-52. PubMed ID: 17315974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New sesquiterpene derivatives from the sponge Dysidea species with a selective inhibitor profile against human phospholipase A2 and other leukocyte functions.
    Giannini C; Debitus C; Lucas R; Ubeda A; Payá M; Hooper JN; D'Auria MV
    J Nat Prod; 2001 May; 64(5):612-5. PubMed ID: 11374954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New polyketides from the sponge Plakortis sp.
    Braekman JC; Daloze D; De Groote S; Fernandes JB; Van Soest RW
    J Nat Prod; 1998 Aug; 61(8):1038-42. PubMed ID: 9722495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and comparison of the antiinflammatory activity of manoalide and cacospongionolide B analogues.
    De Rosa M; Giordano S; Scettri A; Sodano G; Soriente A; Pastor PG; Alcaraz MJ; Payá M
    J Med Chem; 1998 Aug; 41(17):3232-8. PubMed ID: 9703468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sesquiterpenoids of the drimane class from a sponge of the genus Dysidea.
    Paul VJ; Seo Y; Cho KW; Rho JR; Shin J; Bergquist PR
    J Nat Prod; 1997 Nov; 60(11):1115-20. PubMed ID: 9392880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycalamide D, a new cytotoxic amide from the New Zealand marine sponge Mycale species.
    West LM; Northcote PT; Hood KA; Miller JH; Page MJ
    J Nat Prod; 2000 May; 63(5):707-9. PubMed ID: 10843597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New pyridinium alkaloids from a marine sponge of the genus Spongia with a human phospholipase A(2) inhibitor profile.
    De Marino S; Iorizzi M; Zollo F; Debitus C; Menou JL; Ospina LF; Alcaraz MJ; Payá M
    J Nat Prod; 2000 Mar; 63(3):322-6. PubMed ID: 10757711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of petrosaspongiolide M, a novel phospholipase A2 inhibitor, on acute and chronic inflammation.
    Garcia-Pastor P; Randazzo A; Gomez-Paloma L; Alcaraz MJ; Paya M
    J Pharmacol Exp Ther; 1999 Apr; 289(1):166-72. PubMed ID: 10087000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic furanosesterterpenes from a marine sponge Psammocinia sp.
    Choi K; Hong J; Lee CO; Kim DK; Sim CJ; Im KS; Jung JH
    J Nat Prod; 2004 Jul; 67(7):1186-9. PubMed ID: 15270579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new furanosesterterpene from the South African nudibranch Hypselodoris capensis and a dictyoceratida sponge.
    McPhail K; Davies-Coleman MT; Coetzee P
    J Nat Prod; 1998 Jul; 61(7):961-4. PubMed ID: 9677286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cacospongionolide B suppresses the expression of inflammatory enzymes and tumour necrosis factor-alpha by inhibiting nuclear factor-kappa B activation.
    Posadas I; De Rosa S; Terencio MC; Payá M; Alcaraz MJ
    Br J Pharmacol; 2003 Apr; 138(8):1571-9. PubMed ID: 12721113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic compounds from a two-sponge association.
    Jung JH; Sim CJ; Lee CO
    J Nat Prod; 1995 Nov; 58(11):1722-6. PubMed ID: 8594149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic polyacetylenes from the marine sponge Petrosia sp.
    Kim JS; Lim YJ; Im KS; Jung JH; Shim CJ; Lee CO; Hong J; Lee H
    J Nat Prod; 1999 Apr; 62(4):554-9. PubMed ID: 10217707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiflammin-2 (HDMNKVLDL) does not inhibit phospholipase A2 activities.
    Hope WC; Patel BJ; Bolin DR
    Agents Actions; 1991 Sep; 34(1-2):77-80. PubMed ID: 1793057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.